Baxter International Inc.
↗Deerfield, Illinois, USA
Baxter International Inc. is a global leader in medical technology and pharmaceuticals, specializing in products for hemophilia, kidney disease, immune disorders, and other chronic and acute medical conditions. The company operates through three primary segments: Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals.
Following a major strategic restructuring in 2024 and 2025, Baxter divested its Kidney Care business (Vantive) to focus on higher-growth areas in hospital solutions and connected care. The company is a critical supplier of intravenous (IV) fluids, parenteral nutrition, and injectable pharmaceuticals, maintaining a significant manufacturing footprint in North America and globally.
CLASSIFICATION
Company Type:MedTech
Therapeutic Areas:-
Industry:Medical Devices
Sub-Industry:MedTech and Pharmaceuticals
SIZE & FINANCIALS
Employees:10000+
Revenue:$10B-$15B
Founded:1931
Ownership:public
Status:operating
FUNDING
Stage:Public
Investors:Vanguard Group, BlackRock, State Street Global Advisors
STOCK
Exchange:NYSE
Ticker:BAX
Market Cap:$10.83B
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Injectables, IV Solutions, Medical Devices, Digital Health
Active Trials:390
Trial Phases:Phase 1: 45 | Phase 2: 30 | Phase 3: 25 | Phase 4: 15
FDA Approvals:150
EMA Approvals:120
CORPORATE STRUCTURE
Subsidiaries:Hillrom, Baxter Healthcare Corporation
Key Partnerships:MUSC Health (Strategic partnership for bedside care delivery), Vizient (IV fluid supply expansion), University of Texas Medical Branch (Smart pump integration)
COMPETITION
Position:Leader
Competitors:Becton Dickinson (BD), Medtronic, Abbott Laboratories, Boston Scientific, Fresenius Medical Care
LEADERSHIP
Key Executives:
Andrew Hider - CEO
Joel Grade - CFO
Scientific Founders:Donald Baxter
Board Members:Brent Shafer (Chair), William A. Ampofo II, Patricia B. Morrison
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Baxter International Inc.. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.